Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
1.440
+0.050 (3.60%)
At close: May 12, 2025, 4:00 PM
1.470
+0.030 (2.08%)
After-hours: May 12, 2025, 7:04 PM EDT
Atai Life Sciences Market Cap
Atai Life Sciences has a market cap or net worth of $287.70 million as of May 12, 2025. Its market cap has decreased by -8.10% in one year.
Market Cap
287.70M
Enterprise Value
252.28M
1-Year Change
-8.10%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since the IPO on June 18, 2021, Atai Life Sciences's market cap has decreased from $2.29B to $287.70M, a decrease of -87.43%. That is a compound annual growth rate of -41.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 277.72M | 24.44% |
| Dec 31, 2024 | 223.18M | -4.66% |
| Dec 29, 2023 | 234.07M | -46.95% |
| Dec 30, 2022 | 441.23M | -63.92% |
| Dec 31, 2021 | 1.22B | -46.56% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |